{"id":"https://openalex.org/W2020370186","doi":"https://doi.org/10.1517/14740338.2014.909405","title":"Drug safety evaluation of naltrexone/bupropion for the treatment of obesity","display_name":"Drug safety evaluation of naltrexone/bupropion for the treatment of obesity","alternate_titles":[],"publication_year":2014,"publication_date":"2014-04-28","ids":{"openalex":"https://openalex.org/W2020370186","doi":"https://doi.org/10.1517/14740338.2014.909405","mag":"2020370186","pmid":"https://pubmed.ncbi.nlm.nih.gov/24766397"},"language":"en","primary_location":{"id":"doi:10.1517/14740338.2014.909405","doi":"https://doi.org/10.1517/14740338.2014.909405","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.2014.909405","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020370186"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075004932","display_name":"Jessica L. Verpeut","orcid":"https://orcid.org/0000-0003-2941-7697","observed_orcids":["https://orcid.org/0000-0003-2941-7697"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica L Verpeut","raw_affiliation_strings":["Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences, USA","Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences,\n84 Lipman Drive, New Brunswick, NJ 08901, USA+1 848 932 2966"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences, USA","institution_ids":["https://openalex.org/I102322142"]},{"raw_affiliation_string":"Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences,\n84 Lipman Drive, New Brunswick, NJ 08901, USA+1 848 932 2966","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009982619","display_name":"Nicholas T. Bello","orcid":"https://orcid.org/0000-0001-5300-5604","observed_orcids":["https://orcid.org/0000-0001-5300-5604"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas T Bello","raw_affiliation_strings":["Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences, USA","Rutgers, The State University of New Jersey, New Jersey Institute for Food, Nutrition, and Health, USA","Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences,\n84 Lipman Drive, New Brunswick, NJ 08901, USA+1 848 932 2966","Rutgers, The State University of New Jersey, New Jersey Institute for Food, Nutrition, and Health,\nNew Brunswick, NJ 08901, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences, USA","institution_ids":["https://openalex.org/I102322142"]},{"raw_affiliation_string":"Rutgers, The State University of New Jersey, New Jersey Institute for Food, Nutrition, and Health, USA","institution_ids":["https://openalex.org/I102322142"]},{"raw_affiliation_string":"Rutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences,\n84 Lipman Drive, New Brunswick, NJ 08901, USA+1 848 932 2966","institution_ids":["https://openalex.org/I102322142"]},{"raw_affiliation_string":"Rutgers, The State University of New Jersey, New Jersey Institute for Food, Nutrition, and Health,\nNew Brunswick, NJ 08901, USA","institution_ids":["https://openalex.org/I102322142"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I102322142"],"apc_list":null,"apc_paid":null,"fwci":3.8562,"has_fulltext":false,"cited_by_count":211,"citation_normalized_percentile":{"value":0.92556898,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"13","issue":"6","first_page":"831","last_page":"841"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10569","display_name":"Bariatric Surgery and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naltrexone-bupropion","display_name":"naltrexone/bupropion","score":0.9890000224113464},{"id":"https://openalex.org/keywords/obesity-treatment","display_name":"obesity treatment","score":0.8240000009536743},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7770000100135803},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7850000262260437},{"id":"https://openalex.org/keywords/anti-obesity-drugs","display_name":"anti-obesity drugs","score":0.6470000147819519},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.6179999709129333},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.597000002861023},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.8730000257492065},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.8949999809265137},{"id":"https://openalex.org/keywords/orlistat","display_name":"orlistat","score":0.7580000162124634},{"id":"https://openalex.org/keywords/lorcaserin","display_name":"lorcaserin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phentermine-topiramate","display_name":"phentermine/topiramate","score":0.9829999804496765},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.9545506238937378},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.9157603979110718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8743162751197815},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5038811564445496},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4942519962787628},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4728824496269226},{"id":"https://openalex.org/C2775962371","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Opioid antagonist","level":5,"score":0.4627547264099121},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42408913373947144},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.3530534505844116},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24050810933113098},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.2019001841545105},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06370848417282104},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1517/14740338.2014.909405","doi":"https://doi.org/10.1517/14740338.2014.909405","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.2014.909405","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},{"id":"pmid:24766397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24766397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug safety","raw_type":"Comparative Study"},{"id":"pmh:oai:alma.01RUT_INST:11664906430004646","doi":null,"is_oa":false,"landing_page_url":"https://scholarship.libraries.rutgers.edu/esploro/outputs/journalArticle/Drug-safety-evaluation-of-naltrexonebupropion-for/991031665436004646","pdf_url":null,"source":{"id":"https://openalex.org/S4306401388","display_name":"Rutgers University Community Repository (Rutgers University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102322142","host_organization_name":"Rutgers, The State University of New Jersey","host_organization_lineage":["https://openalex.org/I102322142"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":76,"referenced_works":["https://openalex.org/W99661704","https://openalex.org/W192756024","https://openalex.org/W1036826674","https://openalex.org/W1510133720","https://openalex.org/W1518468624","https://openalex.org/W1677634937","https://openalex.org/W1680855902","https://openalex.org/W1710315379","https://openalex.org/W1833305684","https://openalex.org/W1912050742","https://openalex.org/W1927132239","https://openalex.org/W1950326347","https://openalex.org/W1973641964","https://openalex.org/W1974616435","https://openalex.org/W1976028023","https://openalex.org/W1978346929","https://openalex.org/W1987472118","https://openalex.org/W1987721860","https://openalex.org/W1989347831","https://openalex.org/W1991296006","https://openalex.org/W1994122158","https://openalex.org/W1997115741","https://openalex.org/W1999086370","https://openalex.org/W2005136472","https://openalex.org/W2005781055","https://openalex.org/W2009409297","https://openalex.org/W2015371669","https://openalex.org/W2018398248","https://openalex.org/W2019562243","https://openalex.org/W2020982355","https://openalex.org/W2023601754","https://openalex.org/W2023785032","https://openalex.org/W2036737095","https://openalex.org/W2046623047","https://openalex.org/W2046686669","https://openalex.org/W2046738798","https://openalex.org/W2047397850","https://openalex.org/W2047922357","https://openalex.org/W2048363496","https://openalex.org/W2055631198","https://openalex.org/W2057602858","https://openalex.org/W2060530016","https://openalex.org/W2063443884","https://openalex.org/W2065728981","https://openalex.org/W2074115024","https://openalex.org/W2077806570","https://openalex.org/W2079969215","https://openalex.org/W2081286546","https://openalex.org/W2082205780","https://openalex.org/W2084564882","https://openalex.org/W2085917250","https://openalex.org/W2093049395","https://openalex.org/W2093248443","https://openalex.org/W2097590641","https://openalex.org/W2106874613","https://openalex.org/W2108061862","https://openalex.org/W2108559235","https://openalex.org/W2110438413","https://openalex.org/W2113572448","https://openalex.org/W2118987992","https://openalex.org/W2119779723","https://openalex.org/W2120506391","https://openalex.org/W2124353882","https://openalex.org/W2127946577","https://openalex.org/W2137700844","https://openalex.org/W2144589456","https://openalex.org/W2169611151","https://openalex.org/W2171420991","https://openalex.org/W2180294802","https://openalex.org/W2332916265","https://openalex.org/W2399194231","https://openalex.org/W2410319567","https://openalex.org/W2913029280","https://openalex.org/W3172478362","https://openalex.org/W4234808148","https://openalex.org/W4245752492"],"related_works":["https://openalex.org/W1994213874","https://openalex.org/W3097791785","https://openalex.org/W2341654874","https://openalex.org/W2148457688","https://openalex.org/W1869731080","https://openalex.org/W2089415099","https://openalex.org/W2190053653","https://openalex.org/W2083601329","https://openalex.org/W2036089668"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Obesity":[1],"is":[2,34,48,146,163],"a":[3,49,77,116,127],"known":[4],"health":[5],"risk":[6],"for":[7,26,38,66,81],"the":[8,24,27,39,82,92,107,140,150,169],"development":[9],"of":[10,29,41,85,97,109,115,120,153],"several":[11],"preventable":[12],"diseases.":[13],"Obesity-related":[14],"metabolic":[15,78],"alterations":[16],"negatively":[17],"impact":[18],"different":[19],"physiological":[20],"mechanisms,":[21],"which":[22],"supports":[23],"rationale":[25],"use":[28],"combined":[30],"drug":[31],"therapy.":[32],"Naltrexone":[33],"an":[35],"opioid":[36,42],"antagonist":[37],"treatment":[40,84],"and":[43,57,69,76,94,99,102,137,180],"alcohol":[44],"dependency,":[45],"whereas":[46],"bupropion":[47,70,100],"norepinephrine/dopamine":[50],"reuptake":[51],"inhibitor":[52],"used":[53],"to":[54,148],"treat":[55],"depression":[56],"smoking":[58],"cessation.":[59],"Although":[60,139],"not":[61],"effective":[62],"as":[63],"individual":[64],"monotherapies":[65],"obesity,":[67],"naltrexone":[68,98],"in":[71,103],"combination":[72],"produce":[73],"weight":[74,129,141],"loss":[75,130,142],"profile":[79,152],"beneficial":[80],"potential":[83],"obesity.":[86],"AREAS":[87],"COVERED:":[88],"This":[89],"review":[90],"examines":[91],"safety":[93,151],"antiobesity":[95],"effects":[96],"alone":[101],"combination.":[104],"It":[105],"reviews":[106],"results":[108],"four":[110],"Phase":[111],"III":[112],"clinical":[113],"trials":[114],"novel":[117],"fixed":[118],"dose":[119],"sustained-released":[121],"naltrexone/bupropion.":[122],"EXPERT":[123],"OPINION:":[124],"Naltrexone/bupropion":[125],"has":[126,155,183],"greater":[128],"efficacy":[131],"than":[132],"two":[133],"FDA-approved":[134],"medications,":[135,178],"orlistat":[136],"lorcaserin.":[138],"produced":[143],"by":[144],"phentermine/topiramate":[145],"superior":[147],"naltrexone/bupropion,":[149],"naltrexone/bupropion":[154,162,182],"less":[156],"severe":[157],"adverse":[158,172],"effects.":[159],"In":[160],"addition,":[161],"well":[164],"tolerated,":[165],"with":[166],"nausea":[167],"being":[168],"most":[170],"reported":[171],"event.":[173],"Unlike":[174],"other":[175],"centrally":[176],"acting":[177],"lorcaserin":[179],"phentermine/topiramate,":[181],"no":[184],"abuse":[185],"potential.":[186]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020370186","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":159},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":9}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
